Home›People›Sara Ternes
ST

Sara Ternes

Principal Investigator and Chief Operating Officer at ORF Biologics.

ExecutiveDirector
Updated Nov 9, 2026·Latest SEC filing Jul 31, 2026·Suggest an edit

About Sara Ternes

Sara Ternes is a principal investigator and chief operating officer at ORF Biologics.

Sara Ternes first appears on SEC filings in 2024.

Experience

This experience comes from Sara Ternes's profile and from SEC filings. For roles taken from filings, the years are when the filings name Sara Ternes in the role, so the role may have started earlier or lasted longer.

ORF Biologics, Inc. Current
Principal Investigator and Chief Operating Officer
2024 – Present · Tiffin, IA
Designs and makes proteins and other biological products for researchers and drug developers.
Cellular Engineering Technologies
Research Scientist
2012 – 2024

Key Colleagues at Startups

The people Sara Ternes works with at each company, as listed on that company's latest Form D.

ORF Biologics, Inc. · Form D, Jul 31, 2026
JK
Jay Kamath
Executive officer
RB
Roger Baker
Director
AK
Anant Kamath
CEO and director
NT
JH

Sources

  1. SECORF Biologics, Inc. Form D, filed Jul 31, 2026